Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleksander Edelman

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Frontiers in Pharmacology|December 27, 2023
Putting bicarbonate on the spot: pharmacological insights for CFTR correction in the airway epitheliumMiroslaw Zajac, Agathe Lepissier, Elise Dréano, et al.
Molecular & Cellular Proteomics : MCP|July 15, 2005
Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patientsNoura Bensalem, Ana Paula Ventura, Benoît Vallée, et al.
Human Molecular Genetics|November 1, 2011
Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defectJulien Colas, Grazyna Faure, Emilie Saussereau, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Antibodies for CFTR studiesFilipa Mendes, Carlos M Farinha, Mónica Roxo-Rosa, et al.
American Journal of Respiratory and Critical Care Medicine|December 11, 2012
Neutrophil elastase degrades cystic fibrosis transmembrane conductance regulator via calpains and disables channel function in vitro and in vivoMathieu Le Gars, Delphyne Descamps, Delphine Roussel, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 1, 2019
Predictive factors for lumacaftor/ivacaftor clinical responseAlexandra Masson, Elena K Schneider-Futschik, Nesrine Baatallah, et al.
ERJ Open Research|March 3, 2018
Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codonsIwona Pranke, Laure Bidou, Natacha Martin, et al.
Human Mutation|December 23, 2017
Cis variants identified in F508del complex alleles modulate CFTR channel rescue by small moleculesNesrine Baatallah, Sara Bitam, Natacha Martin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 24, 2021
Reclassifying inconclusive diagnosis after newborn screening for cystic fibrosis. Moving forwardAurelie Hatton, Anne Bergougnoux, Katarzyna Zybert, et al.
Atherosclerosis|May 16, 2013
Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic miceIgor G Nikolov, Nobuhiko Joki, Antoine Galmiche, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Frontiers in Pharmacology|December 27, 2023
Putting bicarbonate on the spot: pharmacological insights for CFTR correction in the airway epitheliumMiroslaw Zajac, Agathe Lepissier, Elise Dréano, et al.
Molecular & Cellular Proteomics : MCP|July 15, 2005
Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patientsNoura Bensalem, Ana Paula Ventura, Benoît Vallée, et al.
Human Molecular Genetics|November 1, 2011
Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defectJulien Colas, Grazyna Faure, Emilie Saussereau, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Antibodies for CFTR studiesFilipa Mendes, Carlos M Farinha, Mónica Roxo-Rosa, et al.
American Journal of Respiratory and Critical Care Medicine|December 11, 2012
Neutrophil elastase degrades cystic fibrosis transmembrane conductance regulator via calpains and disables channel function in vitro and in vivoMathieu Le Gars, Delphyne Descamps, Delphine Roussel, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 1, 2019
Predictive factors for lumacaftor/ivacaftor clinical responseAlexandra Masson, Elena K Schneider-Futschik, Nesrine Baatallah, et al.
ERJ Open Research|March 3, 2018
Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codonsIwona Pranke, Laure Bidou, Natacha Martin, et al.
Human Mutation|December 23, 2017
Cis variants identified in F508del complex alleles modulate CFTR channel rescue by small moleculesNesrine Baatallah, Sara Bitam, Natacha Martin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 24, 2021
Reclassifying inconclusive diagnosis after newborn screening for cystic fibrosis. Moving forwardAurelie Hatton, Anne Bergougnoux, Katarzyna Zybert, et al.
Atherosclerosis|May 16, 2013
Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic miceIgor G Nikolov, Nobuhiko Joki, Antoine Galmiche, et al.
Pageof 11